{"gene":"TBX21","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":2000,"finding":"T-bet (TBX21) directly transactivates the IFN-gamma gene and induces endogenous IFN-gamma production; retroviral transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, simultaneously inducing IFN-gamma and repressing IL-4 and IL-5, establishing T-bet as the master regulator of Th1 lineage commitment.","method":"Retroviral gene transduction, ectopic expression, transactivation assays in primary T cells","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — original discovery with multiple functional readouts, highly replicated across the field","pmids":["10761931"],"is_preprint":false},{"year":2001,"finding":"T-bet specifies Th1 effector fate by targeting chromatin remodeling to individual IFN-gamma alleles and by inducing IL-12 receptor beta2 expression, acting upstream of IL-12/STAT4-dependent survival and trans-activation signals.","method":"Allele-specific chromatin remodeling assays, IL-12 receptor expression analysis, genetic epistasis","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods establishing chromatin and signaling mechanisms","pmids":["11397944"],"is_preprint":false},{"year":2001,"finding":"T-bet is rapidly and directly induced by IFN-gamma in a STAT1-dependent but STAT4-independent manner, establishing an autocrine loop whereby IFN-gamma induces T-bet which then promotes further IFN-gamma production.","method":"In vivo infection model (Toxoplasma gondii), IFN-gamma-deficient and STAT1-deficient mice, cytokine stimulation of naive T cells and myeloid cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic knockouts plus in vivo and in vitro stimulation, replicated","pmids":["11752460"],"is_preprint":false},{"year":2002,"finding":"T-bet directly regulates IgG class switching in B cells, particularly to IgG2a; T-bet-deficient B cells cannot generate germline or post-switch IgG2a transcripts in response to IFN-gamma, and enforced T-bet expression initiates IgG2a switching in cell lines and primary cells.","method":"T-bet knockout B cells, retroviral overexpression, germline transcript analysis, in vitro class-switch assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function with molecular readout in B cells","pmids":["11960012"],"is_preprint":false},{"year":2003,"finding":"T-bet is selectively required for IgG2a class-switch recombination in response to T-independent (LPS) but not T-dependent (CD40) stimuli in B cells, identifying T-bet as a class-specific regulator of B cell differentiation.","method":"T-bet-deficient B cell assays with T-independent (LPS) and T-dependent (CD40) stimuli, germline transcript analysis","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with mechanistic dissection of two distinct activation pathways","pmids":["12882831"],"is_preprint":false},{"year":2004,"finding":"T-bet binds directly to the IFN-gamma and STAT1 promoters to regulate their transcription; T-bet-specific antisense oligonucleotides and siRNA suppress T-bet, IFN-gamma, and STAT1 during antigen-specific T cell differentiation, but T-bet does not regulate the IL-12/STAT4 pathway.","method":"Chromatin immunoprecipitation (T-bet binding to IFNg and STAT1 promoters), siRNA/antisense knockdown, in vitro T cell differentiation assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding plus siRNA functional validation","pmids":["15539157"],"is_preprint":false},{"year":2004,"finding":"T-bet function is dominant over STAT1 in EAE: T-bet-deficient mice are resistant to EAE while STAT1-deficient mice are highly susceptible; double T-bet/STAT1 knockout mice are protected, establishing T-bet as the critical downstream effector for Th1-mediated encephalitogenicity.","method":"Genetic epistasis using T-bet KO, STAT1 KO, and double KO mice in EAE model; TCR transgenic crosses","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — rigorous epistasis with multiple genetic combinations","pmids":["15238607"],"is_preprint":false},{"year":2005,"finding":"Notch1 directly regulates Tbx21 transcription through complexes formed on the Tbx21 promoter; gamma-secretase inhibitors block Notch processing and extinguish T-bet and IFN-gamma expression in Th1 cells, while ectopic activated Notch1 restores Tbx21 transcription.","method":"Promoter complex analysis (Notch1 on Tbx21 promoter), gamma-secretase inhibitor treatment, ectopic Notch1 expression, EAE in vivo model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — promoter binding plus gain/loss-of-function with in vivo validation","pmids":["15991363"],"is_preprint":false},{"year":2005,"finding":"T-bet controls migration, survival, and effector functions of Valpha14i NKT cells; ectopic T-bet expression in immature NKT cells is sufficient to drive maturation by inducing Th1-associated cytokines, chemokines, chemokine receptors, and molecules involved in cytolysis.","method":"Microarray gene-expression analysis, in vitro ectopic T-bet expression in immature NKT cells, developmental analysis in T-bet KO mice","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — genome-wide target identification plus gain-of-function reconstitution in NKT cells","pmids":["16357323"],"is_preprint":false},{"year":2006,"finding":"T-bet in dendritic cells is essential for inflammatory arthritis: T-bet regulates IL-1alpha, MIP-1alpha, and TARC production by DCs and is required for T helper cell activation; adoptive transfer of T-bet-expressing DCs reconstitutes inflammation in T-bet-deficient mice.","method":"T-bet KO mice in collagen antibody-induced arthritis (CAIA), RAG2/T-bet double KO, adoptive transfer of T-bet+ DCs","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — adoptive transfer reconstitution with defined cytokine readouts, multiple genetic backgrounds","pmids":["16410834"],"is_preprint":false},{"year":2006,"finding":"T-bet regulates expression of CXCR3 in CD8+ CTL; retroviral CXCR3 expression in T-bet-deficient CD8+ T cells reconstitutes their ability to infiltrate the heart but not to damage it, establishing that T-bet controls both CXCR3-dependent migration and a separate cytotoxicity program.","method":"T-bet KO mice, CXCR3 KO mice, retroviral reconstitution of CXCR3 in T-bet-deficient CD8+ T cells, myocarditis transgenic model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — retroviral reconstitution separating migration from cytotoxicity functions","pmids":["17056513"],"is_preprint":false},{"year":2006,"finding":"T-bet regulates T-independent IgG2a class switching through a pathway that can be bypassed by T-dependent CD40 signaling; T-bet-deficient B cells have normal switching to other IgG isotypes.","method":"T-bet KO B cells stimulated with LPS (T-independent) vs. CD40 ligation (T-dependent), germline transcript analysis","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 2 — clean genetic dissection of two distinct B cell activation pathways","pmids":["12882831"],"is_preprint":false},{"year":2006,"finding":"GATA-3 and T-bet form a transcription factor complex that reciprocally regulates FUT7 (fucosyltransferase VII) gene transcription; T-bet promotes FUT7 transcription and interferes with GATA-3 DNA binding, while GATA-3 competes with CBP/P300 binding to the N-terminus of T-bet and recruits HDAC-3/HDAC-5 to repress FUT7.","method":"EMSA (electrophoretic mobility shift assay), co-immunoprecipitation, dominant-negative GATA-3, luciferase reporter assays, ChIP","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — direct protein-DNA and protein-protein interaction assays with multiple orthogonal methods","pmids":["17075044"],"is_preprint":false},{"year":2007,"finding":"T-bet directly regulates transcription of the IL-23 receptor (IL-23R), influencing Th17 cell fate; siRNA-mediated T-bet silencing in vivo suppresses both Th1 autoreactive T cells and newly differentiated Th17 cells in the CNS in EAE.","method":"siRNA silencing of T-bet in vivo in EAE, IL-23R transcriptional analysis, in vitro T cell differentiation assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA in vivo with direct target gene analysis, single study","pmids":["17237380"],"is_preprint":false},{"year":2007,"finding":"T-bet represses IL-7Ralpha transcription and drives differentiation of effector and effector-memory CD8+ T cells at the expense of central-memory cells; overexpression of T-bet in CD8+ T cells lacking CD4+ help corrects the abnormal phenotype, establishing T-bet as a molecular switch between central- and effector-memory differentiation.","method":"T-bet KO CD8+ T cells, retroviral T-bet overexpression in 'unhelped' CD8+ T cells, memory cell phenotyping","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — loss- and gain-of-function with defined molecular and cellular phenotypes","pmids":["17698591"],"is_preprint":false},{"year":2007,"finding":"T-bet directly and acutely regulates IFN-gamma, CD122 (IL-2/IL-15Rβ), and CXCR3 gene expression as direct targets; temporal control using a tamoxifen-inducible T-bet-estrogen receptor fusion established that these genes respond acutely to T-bet activity.","method":"Inducible T-bet-ER fusion protein controlled by 4-hydroxytamoxifen (tamoxifen-inducible system), gene expression assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — inducible system with temporal dissection confirms direct gene regulation","pmids":["17339440"],"is_preprint":false},{"year":2007,"finding":"T-bet regulates a distant, highly conserved enhancer responsive to both IL-12/STAT4 and IFN-gamma/STAT1 signals; luciferase reporter assays showed both Stat4 and Stat1 activate transcription via this enhancer, providing an IL-12/Stat4/T-bet cascade that regulates IFN-gamma in CD8+ T cells in vivo.","method":"Luciferase reporter assays with wild-type vs. mutated T-bet enhancer, ChIP for Stat4 and Stat1 binding, in vivo virus infection model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 — reporter assays with mutagenesis plus in vivo validation","pmids":["17575072"],"is_preprint":false},{"year":2007,"finding":"T-bet suppresses dermal sclerosis through an IL-13-dependent pathway in innate immune cells; T-bet deficiency in RAG2-deficient mice (lacking T and B cells) still confers increased sensitivity to bleomycin-induced scleroderma, and overexpression of T-bet in T cells does not affect skin sclerosis, establishing the innate immune cell as the relevant compartment.","method":"T-bet KO, RAG2/T-bet double KO, T-bet transgenic overexpression in T cells, bleomycin-induced scleroderma model, cytokine measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models dissecting innate vs. adaptive compartment","pmids":["17307869"],"is_preprint":false},{"year":2009,"finding":"T-bet expression is critical for encephalitogenicity of myelin-specific T cells regardless of whether they produce IFN-gamma or IL-17, indicating T-bet drives pathogenicity through a cytokine-independent pathway.","method":"Myelin-specific TCR transgenic T cells differentiated under Th1 or Th17 conditions, adoptive transfer into EAE-susceptible mice, T-bet expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — adoptive transfer epistasis with T-bet as the critical variable","pmids":["19546248"],"is_preprint":false},{"year":2010,"finding":"T-bet directly regulates Tim-3 expression on Th1 cells; T-bet-deficient Th1 cells fail to upregulate Tim-3, establishing that the Th1-specifying transcription factor also induces the counter-regulatory molecule that terminates Th1 responses.","method":"T-bet KO T cell analysis, T-bet overexpression, Tim-3 expression assays","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — loss/gain-of-function with defined molecular target, single study","pmids":["20049876"],"is_preprint":false},{"year":2010,"finding":"T-bet acts downstream of IFN-gamma and IL-27 (STAT1-activating cytokines) to suppress Th17 responses; ectopic T-bet can suppress IL-17A, IL-17F, IL-22, and RORgammaT even in STAT1-deficient T cells, establishing a STAT1-independent T-bet pathway for Th17 suppression.","method":"T-bet KO, STAT1 KO, double KO mice; ectopic T-bet expression in STAT1-deficient T cells; in vitro priming and in vivo systemic inflammation models","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic backgrounds with ectopic expression, epistasis established","pmids":["20974984"],"is_preprint":false},{"year":2012,"finding":"T-bet (Tbx21) is required for generation of NKp46+ ILC22 cells in the intestinal lamina propria; absence of T-bet causes loss of NKp46+ ILC22 in a cell-intrinsic manner established by bone marrow chimera experiments, and residual NKp46+ ILC22 show reduced RORgammat expression and impaired IL-22 production.","method":"T-bet KO mice, bone marrow chimeras, competitive reconstitution experiments, flow cytometry for ILC subsets","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — cell-intrinsic requirement confirmed by bone marrow chimeras","pmids":["23209316"],"is_preprint":false},{"year":2012,"finding":"T-bet in the innate immune system suppresses IL-7R expression on ILCs to control intestinal ILC homeostasis; loss of T-bet in Tbx21(-/-)Rag2(-/-) (TRUC) mice leads to IL-17A-producing ILC-driven colitis, driven by TNF-alpha from CD103-CD11b+ dendritic cells synergizing with IL-23 to stimulate ILCs.","method":"TRUC mice (Tbx21(-/-)Rag2(-/-)), IL-7R blockade, cytokine measurements, Helicobacter typhlonius identification as disease trigger","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — defined cellular and molecular crosstalk with targeted blockade experiments","pmids":["23063332"],"is_preprint":false},{"year":2013,"finding":"In CCR6-negative RORgammat+ ILCs, graded T-bet expression controls fate decisions: T-bet instructs IFN-gamma production and NKp46 expression; T-bet-deficient mice cannot generate NKp46-expressing RORgammat+ ILCs and fail to produce IFN-gamma, resulting in impaired protection against Salmonella infection.","method":"T-bet KO mice, commensal microbiota manipulation, IL-23 stimulation, Salmonella infection model, genetic fate-mapping","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with defined fate decisions and infection readouts","pmids":["23334414"],"is_preprint":false},{"year":2014,"finding":"T-bet cooperates with Runx3 to suppress conventional CD4+ T helper functions and induce an intraepithelial lymphocyte (IEL) program including CD8alphaalpha homodimer expression; IFN-gamma sensing and T-bet expression are both required for this program.","method":"Gene loss- and gain-of-function (T-bet KO, overexpression), reporter mice, flow cytometry for IEL markers","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic approaches with defined IEL program readout","pmids":["25148025"],"is_preprint":false},{"year":2016,"finding":"T-bet activates Th1 genes through enhancers by recruiting Mediator and P-TEFb in the form of the super elongation complex (SEC), promoting transcriptional elongation; Th1 genes occupied by RNA Pol II in Th2 cells require T-bet-mediated P-TEFb recruitment for productive elongation. This mechanism is independent of NF-kappaB RelA and Brd4.","method":"ChIP-seq, P-TEFb inhibition, Mediator/SEC knockdown, enhancer RNA analysis, EAU model","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 — multiple biochemical and genomic approaches establishing elongation mechanism","pmids":["27292648"],"is_preprint":false},{"year":2016,"finding":"Arid5a, an RNA-binding protein, stabilizes T-bet mRNA by binding to a conserved stem-loop structure in the 3'UTR of T-bet; Arid5a deficiency reduces T-bet mRNA and protein levels in Th1 cells, leading to decreased IFN-gamma production.","method":"Arid5a KO mice, RNA-binding assays (3'UTR stem-loop), Th1 differentiation assays, septic shock model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — direct RNA-binding demonstrated with defined 3'UTR element plus KO phenotype","pmids":["27671645"],"is_preprint":false},{"year":2017,"finding":"mTORC1 promotes T-bet phosphorylation at multiple sites to regulate Th1 differentiation; targeted mass spectrometry identified six T-bet phosphorylation sites, four of which are mTORC1-dependent; simultaneous alanine mutagenesis of three mTORC1-dependent sites significantly reduced IFN-gamma expression by impairing T-bet recruitment of chromatin remodeling complexes to the Ifng promoter.","method":"Multiple reaction monitoring mass spectrometry, Rheb-deficient CD4+ T cells, rapamycin treatment, alanine mutagenesis of phosphorylation sites, ChIP","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — mass spectrometry identification + mutagenesis + chromatin readout","pmids":["28424242"],"is_preprint":false},{"year":2017,"finding":"Egr2 and Egr3 physically interact with the T-box domain of T-bet, blocking T-bet DNA binding and inhibiting T-bet-mediated IFN-gamma production in CD4+ and CD8+ effector T cells.","method":"Co-immunoprecipitation of Egr2/3 with T-bet T-box domain, T-bet DNA binding assays, Egr2/3 KO T cells, in vitro Th1 differentiation and virus infection model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — direct protein-protein interaction mapped to T-box domain plus functional KO validation","pmids":["28455436"],"is_preprint":false},{"year":2017,"finding":"T-bet-expressing B cells (conditional T-bet deletion from B cells) drive germinal center formation and IgG autoantibody production in SLE; B cell-specific T-bet deletion impairs GC formation and mitigates kidney damage in lupus-prone mice.","method":"Conditional B cell-specific T-bet deletion, spontaneous SLE mouse models, GC and autoantibody analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with defined molecular and pathological readouts","pmids":["28240602"],"is_preprint":false},{"year":2017,"finding":"T-bet+ Treg cells become highly stable even under non-permissive conditions; loss of T-bet-expressing Treg cells (but not T-bet expression within Tregs) causes severe Th1 autoimmunity; T-bet+ Tregs specifically inhibit Th1 and CD8 T cell activation consistent with their co-localization with T-bet+ effectors.","method":"T-bet fate-mapping in Treg cells, selective depletion of T-bet+ Tregs, adoptive transfer, infection models in mice","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — fate-mapping plus selective depletion establishing functional necessity","pmids":["28607488"],"is_preprint":false},{"year":2014,"finding":"USP10, a ubiquitin-processing protease, interacts with T-bet in the nucleus and directly inhibits T-bet ubiquitination, thereby increasing T-bet protein stability; the T-bet inhibitor Quercetin targets USP10, promoting T-bet proteasomal degradation.","method":"Co-immunoprecipitation (USP10 with T-bet), overexpression assays, ubiquitination assays, proteasome inhibitor studies","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP and ubiquitination assays, single study with moderate mechanistic follow-up","pmids":["24845384"],"is_preprint":false},{"year":2007,"finding":"Sp1 is a positive transcriptional regulator of human T-BET: six Sp1-binding sites in the proximal T-BET promoter are highly conserved; EMSA demonstrates physical Sp1-promoter association; ectopic Sp1 enhances T-BET expression and cytokine-induced IFN-gamma in NK and T cells; mithramycin A blocks Sp1 binding and diminishes T-BET and IFN-gamma.","method":"EMSA, luciferase reporter assays, Sp1 overexpression, mithramycin A treatment in primary human NK cells","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — EMSA + reporter assays + gain/loss-of-function in primary human cells","pmids":["17705132"],"is_preprint":false},{"year":2012,"finding":"T-bet is an innate target in myeloid cells that directly regulates IL-36gamma transcription; promoter analysis revealed a T-bet binding site enabling efficient IL-36gamma induction; ectopic T-bet expression in keratinocytes (which lack T-bet) is sufficient to mediate IL-36gamma production.","method":"siRNA knockdown + genome-wide mRNA expression, promoter analysis (T-bet binding site identification), T-bet KO dendritic cells, ectopic T-bet expression in HaCaT keratinocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — promoter mapping + siRNA + KO + ectopic expression across multiple cell types","pmids":["23095752"],"is_preprint":false},{"year":2020,"finding":"NEDD4L mediates T-bet ubiquitination and degradation in CD4+ T cells downstream of the DP1/PKA/p-Sp1/NEDD4L pathway; forced NEDD4L expression or T-bet deletion in CD4+ T cells attenuates age-related hypertension.","method":"CD4+ T cell-specific DP1 KO and T-bet KO mice, NEDD4L overexpression, T-bet ubiquitination assays, telemetric blood pressure monitoring","journal":"Circulation","confidence":"Medium","confidence_rationale":"Tier 2-3 — ubiquitination assays plus in vivo genetic models, single study","pmids":["31893939"],"is_preprint":false},{"year":2020,"finding":"c-Maf directly restrains T-bet expression in CCR6- ILC3s and forms a negative feedback loop: T-bet induces c-Maf while c-Maf limits T-bet-driven type 1 programming; loss of c-Maf results in hyper type 1 differentiation with overexpression of ILC1/NK-related genes.","method":"c-Maf KO ILC3 phenotyping, transcriptomic profiling, chromatin analysis, genetic epistasis with T-bet","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — KO + transcriptomic + epistasis establishing direct regulatory relationship","pmids":["32039762"],"is_preprint":false},{"year":2021,"finding":"EOMES and T-BET regulate largely distinct gene sets during NK cell maturation, binding to largely overlapping DNA targets; EOMES drives early lineage specification while T-BET dominates in mature NK cells inducing IL-12 responsiveness and repressing the cell cycle; extensive epigenetic changes accompany this T-BET-driven maturation.","method":"Gene-modified mice with endogenous EOMES/T-BET for ChIP, ChIP-seq, ATAC-seq, NK cell developmental analysis in KO mice","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — ChIP-seq of endogenous proteins + epigenomic analysis + KO phenotypes","pmids":["34521844"],"is_preprint":false},{"year":2021,"finding":"Human T-bet governs the development of a distinct CD11c+CD21low B cell subset by controlling chromatin accessibility of lineage-defining genes (FAS, IL21R, SEC61B, DUSP4, DAPP1, SOX5, CD79B, CXCR4); T-bet-deficient patients lack this B cell subset and show skewed class switching to IgG1/IgG4/IgE with reduced IgG2.","method":"Patient with inherited T-bet deficiency, ATAC-seq (chromatin accessibility), in vitro B cell differentiation assays, in vivo immunoglobulin isotype analysis","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1-2 — human genetic loss-of-function with chromatin accessibility mapping of direct targets","pmids":["35867801"],"is_preprint":false},{"year":2021,"finding":"Wild-type T-bet, but not patient mutant T-bet, inhibits Th2 cytokine production (IL-4, IL-5, IL-9, IL-13) when overexpressed in Th2 cells; T-bet deficiency causes CD4+ αβ T cells to overproduce Th2 cytokines, causing eosinophilia and upper airway inflammation.","method":"Overexpression of WT vs. mutant T-bet in Th2 cells, Herpesvirus saimiri-immortalized T cells from T-bet-deficient patient, cytokine measurement, patient phenotyping","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — natural human experiment with WT vs. mutant rescue, multiple functional readouts","pmids":["34160550"],"is_preprint":false},{"year":2021,"finding":"Expansion of human T-bethigh CD21low B cells requires combined BCR/IFNgamma receptor costimulation and is dependent on canonical NF-kappaB, CD40, IL-21 receptor, and IFNg/STAT1 signaling; TLR signaling via MyD88/IRAK4 is not required. Expansion correlates with circulating Tfh1 and Tph cells as sources of CD40L, IL-21, and IFNgamma.","method":"In vitro differentiation with defined cytokines/TLR ligands, patients with defined inborn errors of immunity (NF-kappaB, CD40, IL-21R, IFNgR, STAT1, MyD88/IRAK4 deficiencies), flow cytometry, transcriptomic and chromatin accessibility analysis","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — natural human genetic experiments across multiple signaling pathways plus in vitro reconstitution","pmids":["34623902"],"is_preprint":false},{"year":2016,"finding":"T-BET expression in Treg cells is required for CXCR3 expression and accumulation of Treg cells in pancreatic islets; genetic ablation of T-BET from Treg cells increases diabetes onset and penetrance in NOD mice by failing to control type 1 cytokine responses.","method":"T-BET conditional KO in Treg cells (NOD mice), CXCR3 expression analysis, insulitis scoring, cytokine measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — conditional cell-type-specific KO with mechanistic (CXCR3) and disease readouts","pmids":["27872297"],"is_preprint":false},{"year":2011,"finding":"Tbx21 locus exhibits bivalent H3K4/H3K27 trimethylation marks in Th17 cells; IL-12 stimulation removes H3K27 trimethylation at Tbx21, enabling T-bet upregulation and Th17-to-Th1 plasticity.","method":"ChIP for H3K4me3 and H3K27me3 at Tbx21, Rorc, Il17a, Ifng, Il12rb2 loci in ex vivo and in vitro Th17 cells, in vivo immunization","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-based epigenetic mechanism at T-bet locus, single study","pmids":["21307296"],"is_preprint":false},{"year":2011,"finding":"Tbx21 gene is expressed in mitral and tufted cells of the olfactory bulb; a ~300 nucleotide enhancer element at ~3.0 kb upstream of the Tbx21 transcription start site is both necessary and sufficient for transgene expression in mitral and tufted cells, revealing a non-immune role for the Tbx21 locus.","method":"Transgenic mice with various lengths of Tbx21 5' upstream region fused to gapVenus reporter, promoter/enhancer deletion analysis","journal":"Neural systems & circuits","confidence":"Medium","confidence_rationale":"Tier 2 — functional enhancer mapping in vivo via transgenic reporter analysis","pmids":["22330144"],"is_preprint":false}],"current_model":"T-bet (TBX21) is a T-box transcription factor that acts as the master regulator of type 1 immune responses: it directly binds the IFN-gamma and other target gene promoters/enhancers (including IL-23R, Tim-3, IL-36gamma, CXCR3, CD122, and FUT7) and recruits Mediator, P-TEFb/SEC, and chromatin remodeling complexes to drive transcriptional elongation; it is induced by IFN-gamma via STAT1 and by IL-12 via STAT4 through a distal enhancer, and its mRNA is stabilized by Arid5a binding the 3'UTR while its protein stability is regulated by USP10-mediated deubiquitination and NEDD4L-mediated ubiquitination; T-bet operates across innate and adaptive immune compartments—governing Th1 CD4+ T cell commitment, CD8+ effector/memory fate decisions, ILC maturation, NK cell terminal differentiation, NKT cell development, B cell IgG2a class switching, and Treg functional specialization—through combinatorial interactions with transcription factors including Runx3, GATA-3, Egr2/3, and c-Maf, making it a pivotal coordinator of type 1 immunity whose dysregulation drives autoimmunity, inflammatory disease, and impaired pathogen clearance."},"narrative":{"teleology":[{"year":2000,"claim":"The discovery that T-bet directly transactivates IFN-γ and redirects Th2 cells to a Th1 fate established TBX21 as the master transcription factor for Th1 lineage commitment, answering the long-standing question of what drives Th1 specification.","evidence":"Retroviral transduction of T-bet into polarized Th2/Tc2 primary T cells with cytokine and transcription assays","pmids":["10761931"],"confidence":"High","gaps":["Genome-wide direct target repertoire not yet defined","Mechanism of Th2 gene repression not established","Role beyond T cells unknown"]},{"year":2001,"claim":"Identification that T-bet targets chromatin remodeling to individual IFN-γ alleles and induces IL-12Rβ2 expression, and that T-bet itself is induced by IFN-γ/STAT1, established the positive-feedback loop (IFN-γ → STAT1 → T-bet → IFN-γ) and placed T-bet upstream of IL-12 signaling.","evidence":"Allele-specific chromatin remodeling assays plus IFN-γ/STAT1/STAT4-deficient mice and in vivo infection models","pmids":["11397944","11752460"],"confidence":"High","gaps":["Precise chromatin remodeling complexes recruited by T-bet not identified","Whether STAT4 independently regulates T-bet expression not resolved"]},{"year":2002,"claim":"Demonstration that T-bet directly regulates IgG2a class switching in B cells extended its functional role beyond T cells, establishing T-bet as a lineage-specifying factor in multiple immune compartments.","evidence":"T-bet KO B cells, retroviral overexpression, germline transcript analysis for IgG2a switching","pmids":["11960012","12882831"],"confidence":"High","gaps":["Whether T-bet directly binds the IgG2a switch region or acts indirectly not determined","Relevance to human B cell class switching unconfirmed"]},{"year":2004,"claim":"ChIP demonstrated direct T-bet binding to IFN-γ and STAT1 promoters, and genetic epistasis showed T-bet is dominant over STAT1 for encephalitogenicity, resolving the hierarchy between T-bet and STAT1 in autoimmune pathogenesis.","evidence":"ChIP for T-bet on IFN-γ/STAT1 promoters; T-bet/STAT1 single and double KO mice in EAE","pmids":["15539157","15238607"],"confidence":"High","gaps":["Mechanism by which T-bet drives pathogenicity independent of IFN-γ not identified","Specific T-bet cofactors at these promoters unknown"]},{"year":2005,"claim":"Notch1 was identified as a direct upstream transcriptional regulator of Tbx21, and T-bet was shown to control NKT cell maturation, broadening the upstream signaling inputs and downstream immune cell types governed by T-bet.","evidence":"Notch1 binding to Tbx21 promoter plus gamma-secretase inhibitor studies; ectopic T-bet expression in immature NKT cells with microarray profiling","pmids":["15991363","16357323"],"confidence":"High","gaps":["Relative contributions of Notch1, STAT1, and STAT4 to T-bet induction in different cell types not quantified","Whether Notch-T-bet axis operates in all T-bet-expressing lineages unknown"]},{"year":2006,"claim":"Multiple studies established that T-bet controls target gene-specific programs in distinct immune compartments: CXCR3-dependent migration versus cytotoxicity in CD8+ T cells, FUT7 via antagonism of GATA-3, and DC-intrinsic cytokine production required for inflammatory arthritis.","evidence":"CXCR3 retroviral reconstitution in T-bet KO CD8+ T cells; EMSA/co-IP of T-bet-GATA3 on FUT7 promoter; adoptive transfer of T-bet+ DCs in arthritis model","pmids":["17056513","17075044","16410834"],"confidence":"High","gaps":["Full spectrum of T-bet direct versus indirect targets in each cell type not delineated","Structural basis of T-bet/GATA-3 antagonism not resolved"]},{"year":2007,"claim":"A temporal dissection using inducible T-bet-ER fusion identified IFN-γ, CD122, and CXCR3 as acute direct targets, while enhancer mapping revealed a distal IL-12/STAT4- and IFN-γ/STAT1-responsive element controlling T-bet expression, defining both inputs and outputs with temporal precision.","evidence":"Tamoxifen-inducible T-bet-ER system; luciferase reporter assays with enhancer mutagenesis; Sp1 EMSA on T-bet promoter; T-bet KO CD8+ memory/effector cell analysis","pmids":["17339440","17575072","17705132","17698591"],"confidence":"High","gaps":["Whether all acute targets represent direct DNA binding or require cofactors not fully resolved","Kinetic hierarchy among direct targets unknown"]},{"year":2009,"claim":"T-bet was shown to be required for encephalitogenicity of myelin-specific T cells independent of whether they produce IFN-γ or IL-17, revealing a cytokine-independent pathogenicity program controlled by T-bet.","evidence":"Adoptive transfer of Th1 or Th17 differentiated myelin-specific TCR transgenic T cells into EAE mice","pmids":["19546248"],"confidence":"High","gaps":["Molecular effectors of this cytokine-independent T-bet pathogenicity program not identified"]},{"year":2010,"claim":"T-bet was found to directly induce Tim-3 (a Th1 counter-regulatory receptor) and to suppress Th17 responses (IL-17A/F, RORγt) through a STAT1-independent mechanism, establishing T-bet as both an activator and a self-limiting regulator of Th1 responses.","evidence":"T-bet KO/overexpression for Tim-3 analysis; ectopic T-bet in STAT1-deficient T cells for Th17 suppression","pmids":["20049876","20974984"],"confidence":"High","gaps":["Whether Tim-3 regulation is a direct promoter event not confirmed by ChIP","Molecular mechanism of STAT1-independent Th17 suppression unclear"]},{"year":2012,"claim":"T-bet was established as essential for ILC biology: required cell-intrinsically for NKp46+ ILC generation and IL-22 production, and for suppressing IL-7R on ILCs to control intestinal homeostasis; its loss in innate cells drives colitis and regulates IL-36γ in myeloid cells.","evidence":"T-bet KO bone marrow chimeras for ILC analysis; TRUC (Tbx21−/−Rag2−/−) mice for colitis; T-bet KO DCs and ectopic expression in keratinocytes for IL-36γ","pmids":["23209316","23063332","23095752"],"confidence":"High","gaps":["Graded T-bet dosage effects on ILC fate decisions not yet defined","Epigenetic mechanism at Tbx21 locus during ILC development not characterized"]},{"year":2013,"claim":"Graded T-bet expression was shown to control fate decisions in RORγt+ ILCs, instructing IFN-γ production and NKp46 expression for protection against Salmonella, establishing a dose-dependent model for T-bet function in innate lymphoid cells.","evidence":"T-bet KO mice with commensal manipulation, IL-23 stimulation, Salmonella infection, genetic fate-mapping","pmids":["23334414"],"confidence":"High","gaps":["Molecular basis by which T-bet dosage is translated into distinct ILC fates not resolved"]},{"year":2014,"claim":"T-bet was found to cooperate with Runx3 to suppress conventional CD4+ T helper functions and induce the CD8αα+ intraepithelial lymphocyte program, and USP10 was identified as a deubiquitinase stabilizing T-bet protein.","evidence":"T-bet/Runx3 loss- and gain-of-function for IEL program; co-IP of USP10 with T-bet plus ubiquitination assays","pmids":["25148025","24845384"],"confidence":"High","gaps":["Structural basis of T-bet–Runx3 cooperation not determined","USP10–T-bet interaction awaits independent confirmation and structural mapping"]},{"year":2016,"claim":"The elongation mechanism was resolved: T-bet activates Th1 genes by recruiting Mediator and P-TEFb/SEC to enhancers to convert poised RNA Pol II into productive elongation, independent of RelA and Brd4; T-bet mRNA was shown to be stabilized by Arid5a binding to a 3′UTR stem-loop; T-bet in Tregs drives CXCR3 expression and islet-accumulation to restrain type 1 diabetes.","evidence":"ChIP-seq/P-TEFb inhibition/Mediator knockdown; Arid5a KO mice with RNA-binding assays; Treg-specific T-bet conditional KO in NOD mice","pmids":["27292648","27671645","27872297"],"confidence":"High","gaps":["Whether the elongation mechanism applies equally to all T-bet target loci not tested","Full repertoire of RNA-binding proteins regulating T-bet mRNA unknown"]},{"year":2017,"claim":"Multiple regulatory layers were defined: mTORC1-dependent phosphorylation at specific T-bet sites controls chromatin complex recruitment; Egr2/3 physically block the T-box DNA-binding domain; T-bet+ Tregs are functionally essential for suppressing Th1/CD8 responses; and B cell-intrinsic T-bet drives lupus germinal center formation.","evidence":"Mass spectrometry of T-bet phosphosites plus mutagenesis; co-IP mapping Egr2/3 to T-box domain; T-bet fate-mapping and depletion in Tregs; conditional B cell-specific T-bet deletion in lupus mice","pmids":["28424242","28455436","28607488","28240602"],"confidence":"High","gaps":["Kinases directly phosphorylating T-bet downstream of mTORC1 not identified","How T-bet+ Tregs acquire distinct suppressive mechanisms versus effector T-bet+ cells not resolved"]},{"year":2020,"claim":"NEDD4L was identified as the E3 ligase mediating T-bet ubiquitination and degradation, and c-Maf was shown to form a negative feedback loop with T-bet in ILC3s restraining type 1 programming.","evidence":"NEDD4L overexpression and T-bet ubiquitination assays in CD4+ T cells with hypertension model; c-Maf KO ILC3 transcriptomic and chromatin analysis with T-bet epistasis","pmids":["31893939","32039762"],"confidence":"Medium","gaps":["Whether NEDD4L is the sole E3 ligase for T-bet not established","Relative contributions of USP10 versus NEDD4L in different cell types not compared"]},{"year":2021,"claim":"Human inherited T-bet deficiency established its non-redundant roles: T-bet governs chromatin accessibility at lineage-defining loci in CD11c+CD21low B cells and is required for Th2 suppression and IgG2 class switching; EOMES and T-bet were shown to regulate largely distinct gene sets during NK maturation despite overlapping DNA binding.","evidence":"Human T-bet-deficient patient with ATAC-seq and in vitro differentiation; WT vs. mutant T-bet rescue in Th2 cells; endogenous ChIP-seq/ATAC-seq of EOMES and T-bet in NK cells; human inborn errors of immunity panel for T-bet+ B cell requirements","pmids":["35867801","34160550","34521844","34623902"],"confidence":"High","gaps":["Full phenotypic spectrum of human T-bet deficiency not yet characterized","How T-bet and EOMES partition target gene regulation at shared binding sites not mechanistically resolved"]},{"year":null,"claim":"Key unresolved questions include the structural basis of T-bet interactions with its diverse partner transcription factors, the complete catalog of direct T-bet targets across all expressing cell types, and the mechanisms by which graded T-bet expression produces qualitatively distinct cell fates.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of T-bet in complex with any partner or DNA","Genome-wide direct target maps across all T-bet-expressing lineages not available","Dose-dependent mechanism converting T-bet levels into distinct ILC/T cell fates not molecularly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,5,12,25,33]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,12,15,25,36]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,25,31,36]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,3,8,21,23,30,37,38]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,5,25,33]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,7,16,27]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,25,37]}],"complexes":[],"partners":["GATA3","RUNX3","EGR2","EGR3","USP10","NEDD4L","ARID5A","MAF"],"other_free_text":[]},"mechanistic_narrative":"TBX21 (T-bet) is a T-box transcription factor that serves as the master regulator of type 1 immune responses across both innate and adaptive immune compartments, governing Th1 CD4+ T cell commitment, CD8+ effector/memory fate, ILC maturation, NK cell terminal differentiation, NKT cell development, B cell IgG2a class switching, and Treg functional specialization [PMID:10761931, PMID:16357323, PMID:23334414, PMID:34521844, PMID:28607488]. T-bet directly transactivates the IFN-gamma gene and additional targets including CXCR3, CD122, Tim-3, IL-23R, IL-36γ, and FUT7 by recruiting Mediator and the super elongation complex (P-TEFb/SEC) to enhancers, thereby promoting transcriptional elongation of poised genes [PMID:27292648, PMID:17339440, PMID:17075044]. Its expression is induced by IFN-γ/STAT1 and IL-12/STAT4 through a distal enhancer, with additional transcriptional input from Notch1 and Sp1, post-transcriptional stabilization of its mRNA by Arid5a, and protein-level regulation through USP10-mediated deubiquitination and NEDD4L-mediated ubiquitin-dependent degradation [PMID:11752460, PMID:17575072, PMID:15991363, PMID:27671645, PMID:24845384, PMID:31893939]. T-bet simultaneously represses alternative lineage programs—suppressing Th2 cytokines through antagonism of GATA-3, Th17 responses through RORγt suppression, and central-memory CD8+ differentiation through IL-7Rα repression—while its activity is modulated by physical interactions with Runx3, Egr2/3, and c-Maf [PMID:12882831, PMID:20974984, PMID:17698591, PMID:28455436, PMID:25148025, PMID:32039762]."},"prefetch_data":{"uniprot":{"accession":"Q9UL17","full_name":"T-box transcription factor TBX21","aliases":["T-cell-specific T-box transcription factor T-bet","Transcription factor TBLYM"],"length_aa":535,"mass_kda":58.3,"function":"Lineage-defining transcription factor which initiates Th1 lineage development from naive Th precursor cells both by activating Th1 genetic programs and by repressing the opposing Th2 and Th17 genetic programs (PubMed:10761931). Activates transcription of a set of genes important for Th1 cell function, including those encoding IFN-gamma and the chemokine receptor CXCR3. Induces permissive chromatin accessibilty and CpG methylation in IFNG (PubMed:33296702). Activates IFNG and CXCR3 genes in part by recruiting chromatin remodeling complexes including KDM6B, a SMARCA4-containing SWI/SNF-complex, and an H3K4me2-methyltransferase complex to their promoters and all of these complexes serve to establish a more permissive chromatin state conducive with transcriptional activation (By similarity). Can activate Th1 genes also via recruitment of Mediator complex and P-TEFb (composed of CDK9 and CCNT1/cyclin-T1) in the form of the super elongation complex (SEC) to super-enhancers and associated genes in activated Th1 cells (PubMed:27292648). Inhibits the Th17 cell lineage commitment by blocking RUNX1-mediated transactivation of Th17 cell-specific transcriptinal regulator RORC. Inhibits the Th2 cell lineage commitment by suppressing the production of Th2 cytokines, such as IL-4, IL-5, and IL- 13, via repression of transcriptional regulators GATA3 and NFATC2. Protects Th1 cells from amplifying aberrant type-I IFN response in an IFN-gamma abundant microenvironment by acting as a repressor of type-I IFN transcription factors and type-I IFN-stimulated genes. Acts as a regulator of antiviral B-cell responses; controls chronic viral infection by promoting the antiviral antibody IgG2a isotype switching and via regulation of a broad antiviral gene expression program (By similarity). Required for the correct development of natural killer (NK) and mucosal-associated invariant T (MAIT) cells (PubMed:33296702)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UL17/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TBX21","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TBX21","total_profiled":1310},"omim":[{"mim_id":"619630","title":"IMMUNODEFICIENCY 88; IMD88","url":"https://www.omim.org/entry/619630"},{"mim_id":"612116","title":"UBIQUITIN-SPECIFIC PROTEASE 22; USP22","url":"https://www.omim.org/entry/612116"},{"mim_id":"610783","title":"MICRO RNA 29B1; MIR29B1","url":"https://www.omim.org/entry/610783"},{"mim_id":"610782","title":"MICRO RNA 29A; MIR29A","url":"https://www.omim.org/entry/610782"},{"mim_id":"609022","title":"RAPAMYCIN-INSENSITIVE COMPANION OF MTOR; RICTOR","url":"https://www.omim.org/entry/609022"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":10.5},{"tissue":"lung","ntpm":3.1},{"tissue":"lymphoid tissue","ntpm":11.0}],"url":"https://www.proteinatlas.org/search/TBX21"},"hgnc":{"alias_symbol":["TBLYM","T-bet"],"prev_symbol":[]},"alphafold":{"accession":"Q9UL17","domains":[{"cath_id":"2.60.40.820","chopping":"130-319","consensus_level":"high","plddt":91.5748,"start":130,"end":319}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UL17","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UL17-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UL17-F1-predicted_aligned_error_v6.png","plddt_mean":60.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBX21","jax_strain_url":"https://www.jax.org/strain/search?query=TBX21"},"sequence":{"accession":"Q9UL17","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UL17.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UL17/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UL17"}},"corpus_meta":[{"pmid":"10761931","id":"PMC_10761931","title":"A novel transcription factor, T-bet, directs Th1 lineage commitment.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10761931","citation_count":2724,"is_preprint":false},{"pmid":"23334414","id":"PMC_23334414","title":"A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23334414","citation_count":616,"is_preprint":false},{"pmid":"11397944","id":"PMC_11397944","title":"Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11397944","citation_count":608,"is_preprint":false},{"pmid":"11752460","id":"PMC_11752460","title":"T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11752460","citation_count":566,"is_preprint":false},{"pmid":"24113868","id":"PMC_24113868","title":"T-bet: a bridge between innate and adaptive immunity.","date":"2013","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24113868","citation_count":396,"is_preprint":false},{"pmid":"11960012","id":"PMC_11960012","title":"T-bet regulates IgG class switching and pathogenic autoantibody production.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11960012","citation_count":389,"is_preprint":false},{"pmid":"15238607","id":"PMC_15238607","title":"Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15238607","citation_count":383,"is_preprint":false},{"pmid":"28607488","id":"PMC_28607488","title":"Stability and function of regulatory T cells expressing the transcription factor T-bet.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28607488","citation_count":330,"is_preprint":false},{"pmid":"15665085","id":"PMC_15665085","title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15665085","citation_count":292,"is_preprint":false},{"pmid":"23063332","id":"PMC_23063332","title":"The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells.","date":"2012","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23063332","citation_count":285,"is_preprint":false},{"pmid":"15991363","id":"PMC_15991363","title":"Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21.","date":"2005","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15991363","citation_count":255,"is_preprint":false},{"pmid":"17698591","id":"PMC_17698591","title":"Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17698591","citation_count":236,"is_preprint":false},{"pmid":"19546248","id":"PMC_19546248","title":"T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19546248","citation_count":226,"is_preprint":false},{"pmid":"28240602","id":"PMC_28240602","title":"B cells expressing the transcription factor T-bet drive lupus-like autoimmunity.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/28240602","citation_count":224,"is_preprint":false},{"pmid":"17237380","id":"PMC_17237380","title":"T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17237380","citation_count":210,"is_preprint":false},{"pmid":"21685955","id":"PMC_21685955","title":"T-bet in disease.","date":"2011","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21685955","citation_count":199,"is_preprint":false},{"pmid":"26297793","id":"PMC_26297793","title":"Age-Associated B Cells: A T-bet-Dependent Effector with Roles in Protective and Pathogenic Immunity.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26297793","citation_count":198,"is_preprint":false},{"pmid":"24860576","id":"PMC_24860576","title":"Characterization of T-bet and eomes in peripheral human immune cells.","date":"2014","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24860576","citation_count":167,"is_preprint":false},{"pmid":"28422752","id":"PMC_28422752","title":"T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28422752","citation_count":152,"is_preprint":false},{"pmid":"15539157","id":"PMC_15539157","title":"Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes.","date":"2004","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15539157","citation_count":151,"is_preprint":false},{"pmid":"23209316","id":"PMC_23209316","title":"Distinct requirements for T-bet in gut innate lymphoid cells.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23209316","citation_count":147,"is_preprint":false},{"pmid":"28756897","id":"PMC_28756897","title":"Role of CD11c+ T-bet+ B cells in human health and disease.","date":"2017","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28756897","citation_count":142,"is_preprint":false},{"pmid":"28279590","id":"PMC_28279590","title":"Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System.","date":"2017","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28279590","citation_count":123,"is_preprint":false},{"pmid":"16434488","id":"PMC_16434488","title":"T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16434488","citation_count":122,"is_preprint":false},{"pmid":"27021296","id":"PMC_27021296","title":"CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.","date":"2016","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/27021296","citation_count":120,"is_preprint":false},{"pmid":"34623902","id":"PMC_34623902","title":"The expansion of human T-bethighCD21low B cells is T cell dependent.","date":"2021","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34623902","citation_count":120,"is_preprint":false},{"pmid":"16357323","id":"PMC_16357323","title":"T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16357323","citation_count":115,"is_preprint":false},{"pmid":"15306590","id":"PMC_15306590","title":"T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.","date":"2004","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/15306590","citation_count":115,"is_preprint":false},{"pmid":"30874358","id":"PMC_30874358","title":"T-bet+ memory B cells: Generation, function, and fate.","date":"2019","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30874358","citation_count":112,"is_preprint":false},{"pmid":"25148025","id":"PMC_25148025","title":"Transcription factor T-bet regulates intraepithelial lymphocyte functional maturation.","date":"2014","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25148025","citation_count":111,"is_preprint":false},{"pmid":"27379101","id":"PMC_27379101","title":"T-bet and Eomesodermin in NK Cell Development, Maturation, and Function.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27379101","citation_count":110,"is_preprint":false},{"pmid":"12882831","id":"PMC_12882831","title":"T-bet regulates T-independent IgG2a class switching.","date":"2003","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12882831","citation_count":106,"is_preprint":false},{"pmid":"20974984","id":"PMC_20974984","title":"STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20974984","citation_count":102,"is_preprint":false},{"pmid":"16410834","id":"PMC_16410834","title":"Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16410834","citation_count":100,"is_preprint":false},{"pmid":"20049876","id":"PMC_20049876","title":"T-bet, a Th1 transcription factor regulates the expression of Tim-3.","date":"2010","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20049876","citation_count":93,"is_preprint":false},{"pmid":"17307869","id":"PMC_17307869","title":"Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17307869","citation_count":91,"is_preprint":false},{"pmid":"27872297","id":"PMC_27872297","title":"Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27872297","citation_count":89,"is_preprint":false},{"pmid":"16614350","id":"PMC_16614350","title":"Transcription factors T-bet and GATA-3 regulate development of airway remodeling.","date":"2006","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16614350","citation_count":88,"is_preprint":false},{"pmid":"31776286","id":"PMC_31776286","title":"Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.","date":"2019","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31776286","citation_count":85,"is_preprint":false},{"pmid":"34521844","id":"PMC_34521844","title":"Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34521844","citation_count":78,"is_preprint":false},{"pmid":"31136008","id":"PMC_31136008","title":"Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis.","date":"2019","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31136008","citation_count":77,"is_preprint":false},{"pmid":"17075044","id":"PMC_17075044","title":"Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17075044","citation_count":75,"is_preprint":false},{"pmid":"17575072","id":"PMC_17575072","title":"Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17575072","citation_count":69,"is_preprint":false},{"pmid":"29101363","id":"PMC_29101363","title":"Plasmodium DNA-mediated TLR9 activation of T-bet+ B cells contributes to autoimmune anaemia during malaria.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29101363","citation_count":68,"is_preprint":false},{"pmid":"35868310","id":"PMC_35868310","title":"T-bet+ B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity.","date":"2022","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35868310","citation_count":67,"is_preprint":false},{"pmid":"15806396","id":"PMC_15806396","title":"Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15806396","citation_count":66,"is_preprint":false},{"pmid":"35867801","id":"PMC_35867801","title":"Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35867801","citation_count":65,"is_preprint":false},{"pmid":"30846856","id":"PMC_30846856","title":"The evolving role of T-bet in resistance to infection.","date":"2019","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30846856","citation_count":63,"is_preprint":false},{"pmid":"16204645","id":"PMC_16204645","title":"Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.","date":"2005","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/16204645","citation_count":61,"is_preprint":false},{"pmid":"17339440","id":"PMC_17339440","title":"Temporal dissection of T-bet functions.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17339440","citation_count":60,"is_preprint":false},{"pmid":"27230441","id":"PMC_27230441","title":"Expanded lung T-bet+RORγT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype.","date":"2016","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/27230441","citation_count":59,"is_preprint":false},{"pmid":"23095752","id":"PMC_23095752","title":"IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23095752","citation_count":54,"is_preprint":false},{"pmid":"17056513","id":"PMC_17056513","title":"T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17056513","citation_count":54,"is_preprint":false},{"pmid":"27292648","id":"PMC_27292648","title":"T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27292648","citation_count":53,"is_preprint":false},{"pmid":"25541140","id":"PMC_25541140","title":"TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity.","date":"2014","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25541140","citation_count":52,"is_preprint":false},{"pmid":"27671645","id":"PMC_27671645","title":"Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27671645","citation_count":52,"is_preprint":false},{"pmid":"28423310","id":"PMC_28423310","title":"c-Myb Regulates the T-Bet-Dependent Differentiation Program in B Cells to Coordinate Antibody Responses.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28423310","citation_count":51,"is_preprint":false},{"pmid":"21307296","id":"PMC_21307296","title":"Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21307296","citation_count":50,"is_preprint":false},{"pmid":"24934598","id":"PMC_24934598","title":"MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis.","date":"2014","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/24934598","citation_count":50,"is_preprint":false},{"pmid":"28739077","id":"PMC_28739077","title":"T-bet-expressing B cells during HIV and HCV infections.","date":"2017","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28739077","citation_count":49,"is_preprint":false},{"pmid":"34675939","id":"PMC_34675939","title":"Expression Regulation and Function of T-Bet in NK Cells.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34675939","citation_count":49,"is_preprint":false},{"pmid":"24495857","id":"PMC_24495857","title":"The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.","date":"2014","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/24495857","citation_count":47,"is_preprint":false},{"pmid":"24078698","id":"PMC_24078698","title":"The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24078698","citation_count":46,"is_preprint":false},{"pmid":"16785492","id":"PMC_16785492","title":"Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16785492","citation_count":46,"is_preprint":false},{"pmid":"28923237","id":"PMC_28923237","title":"Signals that drive T-bet expression in B cells.","date":"2017","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28923237","citation_count":45,"is_preprint":false},{"pmid":"22330144","id":"PMC_22330144","title":"Genetic visualization of the secondary olfactory pathway in Tbx21 transgenic mice.","date":"2011","source":"Neural systems & circuits","url":"https://pubmed.ncbi.nlm.nih.gov/22330144","citation_count":43,"is_preprint":false},{"pmid":"15528324","id":"PMC_15528324","title":"Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15528324","citation_count":43,"is_preprint":false},{"pmid":"34806650","id":"PMC_34806650","title":"YY1 regulation by miR-124-3p promotes Th17 cell pathogenicity through interaction with T-bet in rheumatoid arthritis.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34806650","citation_count":42,"is_preprint":false},{"pmid":"24415778","id":"PMC_24415778","title":"KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24415778","citation_count":42,"is_preprint":false},{"pmid":"25556247","id":"PMC_25556247","title":"Diverse roles for T-bet in the effector responses required for resistance to infection.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25556247","citation_count":41,"is_preprint":false},{"pmid":"15241679","id":"PMC_15241679","title":"Identification of a novel type 1 diabetes susceptibility gene, T-bet.","date":"2004","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15241679","citation_count":41,"is_preprint":false},{"pmid":"28424242","id":"PMC_28424242","title":"mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28424242","citation_count":40,"is_preprint":false},{"pmid":"16220539","id":"PMC_16220539","title":"IL-12 up-regulates T-bet independently of IFN-gamma in human CD4+ T cells.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16220539","citation_count":40,"is_preprint":false},{"pmid":"24845384","id":"PMC_24845384","title":"Deubiquitination and stabilization of T-bet by USP10.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24845384","citation_count":39,"is_preprint":false},{"pmid":"12007433","id":"PMC_12007433","title":"Asthma: T-bet--a master controller?","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12007433","citation_count":37,"is_preprint":false},{"pmid":"29367462","id":"PMC_29367462","title":"High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29367462","citation_count":37,"is_preprint":false},{"pmid":"29515240","id":"PMC_29515240","title":"T-bet promotes potent antitumor activity of CD4+ CAR T cells.","date":"2018","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29515240","citation_count":36,"is_preprint":false},{"pmid":"28289707","id":"PMC_28289707","title":"Eomesodermin and T-bet mark developmentally distinct human natural killer cells.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28289707","citation_count":36,"is_preprint":false},{"pmid":"30784957","id":"PMC_30784957","title":"T-bet+ B cells: A common denominator in protective and autoreactive antibody responses?","date":"2019","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30784957","citation_count":34,"is_preprint":false},{"pmid":"19691533","id":"PMC_19691533","title":"pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy.","date":"2009","source":"Journal of the peripheral nervous system : JPNS","url":"https://pubmed.ncbi.nlm.nih.gov/19691533","citation_count":33,"is_preprint":false},{"pmid":"32039762","id":"PMC_32039762","title":"c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32039762","citation_count":32,"is_preprint":false},{"pmid":"17705132","id":"PMC_17705132","title":"Transcriptional control of human T-BET expression: the role of Sp1.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17705132","citation_count":32,"is_preprint":false},{"pmid":"34160550","id":"PMC_34160550","title":"High Th2 cytokine levels and upper airway inflammation in human inherited T-bet deficiency.","date":"2021","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34160550","citation_count":31,"is_preprint":false},{"pmid":"34032636","id":"PMC_34032636","title":"T-bet+CD27+CD21- B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34032636","citation_count":30,"is_preprint":false},{"pmid":"31893939","id":"PMC_31893939","title":"DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells.","date":"2020","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/31893939","citation_count":30,"is_preprint":false},{"pmid":"16234441","id":"PMC_16234441","title":"Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease.","date":"2005","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/16234441","citation_count":30,"is_preprint":false},{"pmid":"34017332","id":"PMC_34017332","title":"Mass Cytometry Identifies Expansion of T-bet+ B Cells and CD206+ Monocytes in Early Multiple Sclerosis.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34017332","citation_count":29,"is_preprint":false},{"pmid":"20237292","id":"PMC_20237292","title":"Lck mediates Th2 differentiation through effects on T-bet and GATA-3.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20237292","citation_count":29,"is_preprint":false},{"pmid":"26916970","id":"PMC_26916970","title":"Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26916970","citation_count":29,"is_preprint":false},{"pmid":"30825520","id":"PMC_30825520","title":"CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis.","date":"2019","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30825520","citation_count":28,"is_preprint":false},{"pmid":"30687330","id":"PMC_30687330","title":"RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis-Novel Targets for Therapy?","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30687330","citation_count":26,"is_preprint":false},{"pmid":"21905017","id":"PMC_21905017","title":"Overexpression of T-bet gene regulates murine autoimmune arthritis.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21905017","citation_count":26,"is_preprint":false},{"pmid":"28455436","id":"PMC_28455436","title":"Egr2 and 3 Inhibit T-bet-Mediated IFN-γ Production in T Cells.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28455436","citation_count":26,"is_preprint":false},{"pmid":"12210112","id":"PMC_12210112","title":"Evolution of developmental functions by the Eomesodermin, T-brain-1, Tbx21 subfamily of T-box genes: insights from amphioxus.","date":"2002","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/12210112","citation_count":26,"is_preprint":false},{"pmid":"29445199","id":"PMC_29445199","title":"Lack of T-bet reduces monocytic interleukin-12 formation and accelerates thrombus resolution in deep vein thrombosis.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29445199","citation_count":26,"is_preprint":false},{"pmid":"27670243","id":"PMC_27670243","title":"T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.","date":"2016","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27670243","citation_count":25,"is_preprint":false},{"pmid":"24575371","id":"PMC_24575371","title":"The immune cell transcription factor T-bet: A novel metabolic regulator.","date":"2013","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/24575371","citation_count":25,"is_preprint":false},{"pmid":"22160839","id":"PMC_22160839","title":"Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3.","date":"2012","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22160839","citation_count":25,"is_preprint":false},{"pmid":"25092994","id":"PMC_25092994","title":"Linking obesity with type 2 diabetes: the role of T-bet.","date":"2014","source":"Diabetes, metabolic syndrome and obesity : targets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25092994","citation_count":24,"is_preprint":false},{"pmid":"19287198","id":"PMC_19287198","title":"Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis.","date":"2009","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19287198","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43869,"output_tokens":9836,"usd":0.139573},"stage2":{"model":"claude-opus-4-6","input_tokens":13753,"output_tokens":4558,"usd":0.274072},"total_usd":0.413645,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"T-bet (TBX21) directly transactivates the IFN-gamma gene and induces endogenous IFN-gamma production; retroviral transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, simultaneously inducing IFN-gamma and repressing IL-4 and IL-5, establishing T-bet as the master regulator of Th1 lineage commitment.\",\n      \"method\": \"Retroviral gene transduction, ectopic expression, transactivation assays in primary T cells\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original discovery with multiple functional readouts, highly replicated across the field\",\n      \"pmids\": [\"10761931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"T-bet specifies Th1 effector fate by targeting chromatin remodeling to individual IFN-gamma alleles and by inducing IL-12 receptor beta2 expression, acting upstream of IL-12/STAT4-dependent survival and trans-activation signals.\",\n      \"method\": \"Allele-specific chromatin remodeling assays, IL-12 receptor expression analysis, genetic epistasis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods establishing chromatin and signaling mechanisms\",\n      \"pmids\": [\"11397944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"T-bet is rapidly and directly induced by IFN-gamma in a STAT1-dependent but STAT4-independent manner, establishing an autocrine loop whereby IFN-gamma induces T-bet which then promotes further IFN-gamma production.\",\n      \"method\": \"In vivo infection model (Toxoplasma gondii), IFN-gamma-deficient and STAT1-deficient mice, cytokine stimulation of naive T cells and myeloid cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockouts plus in vivo and in vitro stimulation, replicated\",\n      \"pmids\": [\"11752460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"T-bet directly regulates IgG class switching in B cells, particularly to IgG2a; T-bet-deficient B cells cannot generate germline or post-switch IgG2a transcripts in response to IFN-gamma, and enforced T-bet expression initiates IgG2a switching in cell lines and primary cells.\",\n      \"method\": \"T-bet knockout B cells, retroviral overexpression, germline transcript analysis, in vitro class-switch assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function with molecular readout in B cells\",\n      \"pmids\": [\"11960012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"T-bet is selectively required for IgG2a class-switch recombination in response to T-independent (LPS) but not T-dependent (CD40) stimuli in B cells, identifying T-bet as a class-specific regulator of B cell differentiation.\",\n      \"method\": \"T-bet-deficient B cell assays with T-independent (LPS) and T-dependent (CD40) stimuli, germline transcript analysis\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with mechanistic dissection of two distinct activation pathways\",\n      \"pmids\": [\"12882831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"T-bet binds directly to the IFN-gamma and STAT1 promoters to regulate their transcription; T-bet-specific antisense oligonucleotides and siRNA suppress T-bet, IFN-gamma, and STAT1 during antigen-specific T cell differentiation, but T-bet does not regulate the IL-12/STAT4 pathway.\",\n      \"method\": \"Chromatin immunoprecipitation (T-bet binding to IFNg and STAT1 promoters), siRNA/antisense knockdown, in vitro T cell differentiation assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding plus siRNA functional validation\",\n      \"pmids\": [\"15539157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"T-bet function is dominant over STAT1 in EAE: T-bet-deficient mice are resistant to EAE while STAT1-deficient mice are highly susceptible; double T-bet/STAT1 knockout mice are protected, establishing T-bet as the critical downstream effector for Th1-mediated encephalitogenicity.\",\n      \"method\": \"Genetic epistasis using T-bet KO, STAT1 KO, and double KO mice in EAE model; TCR transgenic crosses\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous epistasis with multiple genetic combinations\",\n      \"pmids\": [\"15238607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Notch1 directly regulates Tbx21 transcription through complexes formed on the Tbx21 promoter; gamma-secretase inhibitors block Notch processing and extinguish T-bet and IFN-gamma expression in Th1 cells, while ectopic activated Notch1 restores Tbx21 transcription.\",\n      \"method\": \"Promoter complex analysis (Notch1 on Tbx21 promoter), gamma-secretase inhibitor treatment, ectopic Notch1 expression, EAE in vivo model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — promoter binding plus gain/loss-of-function with in vivo validation\",\n      \"pmids\": [\"15991363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"T-bet controls migration, survival, and effector functions of Valpha14i NKT cells; ectopic T-bet expression in immature NKT cells is sufficient to drive maturation by inducing Th1-associated cytokines, chemokines, chemokine receptors, and molecules involved in cytolysis.\",\n      \"method\": \"Microarray gene-expression analysis, in vitro ectopic T-bet expression in immature NKT cells, developmental analysis in T-bet KO mice\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide target identification plus gain-of-function reconstitution in NKT cells\",\n      \"pmids\": [\"16357323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"T-bet in dendritic cells is essential for inflammatory arthritis: T-bet regulates IL-1alpha, MIP-1alpha, and TARC production by DCs and is required for T helper cell activation; adoptive transfer of T-bet-expressing DCs reconstitutes inflammation in T-bet-deficient mice.\",\n      \"method\": \"T-bet KO mice in collagen antibody-induced arthritis (CAIA), RAG2/T-bet double KO, adoptive transfer of T-bet+ DCs\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — adoptive transfer reconstitution with defined cytokine readouts, multiple genetic backgrounds\",\n      \"pmids\": [\"16410834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"T-bet regulates expression of CXCR3 in CD8+ CTL; retroviral CXCR3 expression in T-bet-deficient CD8+ T cells reconstitutes their ability to infiltrate the heart but not to damage it, establishing that T-bet controls both CXCR3-dependent migration and a separate cytotoxicity program.\",\n      \"method\": \"T-bet KO mice, CXCR3 KO mice, retroviral reconstitution of CXCR3 in T-bet-deficient CD8+ T cells, myocarditis transgenic model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — retroviral reconstitution separating migration from cytotoxicity functions\",\n      \"pmids\": [\"17056513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"T-bet regulates T-independent IgG2a class switching through a pathway that can be bypassed by T-dependent CD40 signaling; T-bet-deficient B cells have normal switching to other IgG isotypes.\",\n      \"method\": \"T-bet KO B cells stimulated with LPS (T-independent) vs. CD40 ligation (T-dependent), germline transcript analysis\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic dissection of two distinct B cell activation pathways\",\n      \"pmids\": [\"12882831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GATA-3 and T-bet form a transcription factor complex that reciprocally regulates FUT7 (fucosyltransferase VII) gene transcription; T-bet promotes FUT7 transcription and interferes with GATA-3 DNA binding, while GATA-3 competes with CBP/P300 binding to the N-terminus of T-bet and recruits HDAC-3/HDAC-5 to repress FUT7.\",\n      \"method\": \"EMSA (electrophoretic mobility shift assay), co-immunoprecipitation, dominant-negative GATA-3, luciferase reporter assays, ChIP\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct protein-DNA and protein-protein interaction assays with multiple orthogonal methods\",\n      \"pmids\": [\"17075044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"T-bet directly regulates transcription of the IL-23 receptor (IL-23R), influencing Th17 cell fate; siRNA-mediated T-bet silencing in vivo suppresses both Th1 autoreactive T cells and newly differentiated Th17 cells in the CNS in EAE.\",\n      \"method\": \"siRNA silencing of T-bet in vivo in EAE, IL-23R transcriptional analysis, in vitro T cell differentiation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA in vivo with direct target gene analysis, single study\",\n      \"pmids\": [\"17237380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"T-bet represses IL-7Ralpha transcription and drives differentiation of effector and effector-memory CD8+ T cells at the expense of central-memory cells; overexpression of T-bet in CD8+ T cells lacking CD4+ help corrects the abnormal phenotype, establishing T-bet as a molecular switch between central- and effector-memory differentiation.\",\n      \"method\": \"T-bet KO CD8+ T cells, retroviral T-bet overexpression in 'unhelped' CD8+ T cells, memory cell phenotyping\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function with defined molecular and cellular phenotypes\",\n      \"pmids\": [\"17698591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"T-bet directly and acutely regulates IFN-gamma, CD122 (IL-2/IL-15Rβ), and CXCR3 gene expression as direct targets; temporal control using a tamoxifen-inducible T-bet-estrogen receptor fusion established that these genes respond acutely to T-bet activity.\",\n      \"method\": \"Inducible T-bet-ER fusion protein controlled by 4-hydroxytamoxifen (tamoxifen-inducible system), gene expression assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — inducible system with temporal dissection confirms direct gene regulation\",\n      \"pmids\": [\"17339440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"T-bet regulates a distant, highly conserved enhancer responsive to both IL-12/STAT4 and IFN-gamma/STAT1 signals; luciferase reporter assays showed both Stat4 and Stat1 activate transcription via this enhancer, providing an IL-12/Stat4/T-bet cascade that regulates IFN-gamma in CD8+ T cells in vivo.\",\n      \"method\": \"Luciferase reporter assays with wild-type vs. mutated T-bet enhancer, ChIP for Stat4 and Stat1 binding, in vivo virus infection model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reporter assays with mutagenesis plus in vivo validation\",\n      \"pmids\": [\"17575072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"T-bet suppresses dermal sclerosis through an IL-13-dependent pathway in innate immune cells; T-bet deficiency in RAG2-deficient mice (lacking T and B cells) still confers increased sensitivity to bleomycin-induced scleroderma, and overexpression of T-bet in T cells does not affect skin sclerosis, establishing the innate immune cell as the relevant compartment.\",\n      \"method\": \"T-bet KO, RAG2/T-bet double KO, T-bet transgenic overexpression in T cells, bleomycin-induced scleroderma model, cytokine measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models dissecting innate vs. adaptive compartment\",\n      \"pmids\": [\"17307869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"T-bet expression is critical for encephalitogenicity of myelin-specific T cells regardless of whether they produce IFN-gamma or IL-17, indicating T-bet drives pathogenicity through a cytokine-independent pathway.\",\n      \"method\": \"Myelin-specific TCR transgenic T cells differentiated under Th1 or Th17 conditions, adoptive transfer into EAE-susceptible mice, T-bet expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — adoptive transfer epistasis with T-bet as the critical variable\",\n      \"pmids\": [\"19546248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"T-bet directly regulates Tim-3 expression on Th1 cells; T-bet-deficient Th1 cells fail to upregulate Tim-3, establishing that the Th1-specifying transcription factor also induces the counter-regulatory molecule that terminates Th1 responses.\",\n      \"method\": \"T-bet KO T cell analysis, T-bet overexpression, Tim-3 expression assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss/gain-of-function with defined molecular target, single study\",\n      \"pmids\": [\"20049876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"T-bet acts downstream of IFN-gamma and IL-27 (STAT1-activating cytokines) to suppress Th17 responses; ectopic T-bet can suppress IL-17A, IL-17F, IL-22, and RORgammaT even in STAT1-deficient T cells, establishing a STAT1-independent T-bet pathway for Th17 suppression.\",\n      \"method\": \"T-bet KO, STAT1 KO, double KO mice; ectopic T-bet expression in STAT1-deficient T cells; in vitro priming and in vivo systemic inflammation models\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic backgrounds with ectopic expression, epistasis established\",\n      \"pmids\": [\"20974984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"T-bet (Tbx21) is required for generation of NKp46+ ILC22 cells in the intestinal lamina propria; absence of T-bet causes loss of NKp46+ ILC22 in a cell-intrinsic manner established by bone marrow chimera experiments, and residual NKp46+ ILC22 show reduced RORgammat expression and impaired IL-22 production.\",\n      \"method\": \"T-bet KO mice, bone marrow chimeras, competitive reconstitution experiments, flow cytometry for ILC subsets\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-intrinsic requirement confirmed by bone marrow chimeras\",\n      \"pmids\": [\"23209316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"T-bet in the innate immune system suppresses IL-7R expression on ILCs to control intestinal ILC homeostasis; loss of T-bet in Tbx21(-/-)Rag2(-/-) (TRUC) mice leads to IL-17A-producing ILC-driven colitis, driven by TNF-alpha from CD103-CD11b+ dendritic cells synergizing with IL-23 to stimulate ILCs.\",\n      \"method\": \"TRUC mice (Tbx21(-/-)Rag2(-/-)), IL-7R blockade, cytokine measurements, Helicobacter typhlonius identification as disease trigger\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular and molecular crosstalk with targeted blockade experiments\",\n      \"pmids\": [\"23063332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In CCR6-negative RORgammat+ ILCs, graded T-bet expression controls fate decisions: T-bet instructs IFN-gamma production and NKp46 expression; T-bet-deficient mice cannot generate NKp46-expressing RORgammat+ ILCs and fail to produce IFN-gamma, resulting in impaired protection against Salmonella infection.\",\n      \"method\": \"T-bet KO mice, commensal microbiota manipulation, IL-23 stimulation, Salmonella infection model, genetic fate-mapping\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with defined fate decisions and infection readouts\",\n      \"pmids\": [\"23334414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"T-bet cooperates with Runx3 to suppress conventional CD4+ T helper functions and induce an intraepithelial lymphocyte (IEL) program including CD8alphaalpha homodimer expression; IFN-gamma sensing and T-bet expression are both required for this program.\",\n      \"method\": \"Gene loss- and gain-of-function (T-bet KO, overexpression), reporter mice, flow cytometry for IEL markers\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic approaches with defined IEL program readout\",\n      \"pmids\": [\"25148025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"T-bet activates Th1 genes through enhancers by recruiting Mediator and P-TEFb in the form of the super elongation complex (SEC), promoting transcriptional elongation; Th1 genes occupied by RNA Pol II in Th2 cells require T-bet-mediated P-TEFb recruitment for productive elongation. This mechanism is independent of NF-kappaB RelA and Brd4.\",\n      \"method\": \"ChIP-seq, P-TEFb inhibition, Mediator/SEC knockdown, enhancer RNA analysis, EAU model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biochemical and genomic approaches establishing elongation mechanism\",\n      \"pmids\": [\"27292648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arid5a, an RNA-binding protein, stabilizes T-bet mRNA by binding to a conserved stem-loop structure in the 3'UTR of T-bet; Arid5a deficiency reduces T-bet mRNA and protein levels in Th1 cells, leading to decreased IFN-gamma production.\",\n      \"method\": \"Arid5a KO mice, RNA-binding assays (3'UTR stem-loop), Th1 differentiation assays, septic shock model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct RNA-binding demonstrated with defined 3'UTR element plus KO phenotype\",\n      \"pmids\": [\"27671645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"mTORC1 promotes T-bet phosphorylation at multiple sites to regulate Th1 differentiation; targeted mass spectrometry identified six T-bet phosphorylation sites, four of which are mTORC1-dependent; simultaneous alanine mutagenesis of three mTORC1-dependent sites significantly reduced IFN-gamma expression by impairing T-bet recruitment of chromatin remodeling complexes to the Ifng promoter.\",\n      \"method\": \"Multiple reaction monitoring mass spectrometry, Rheb-deficient CD4+ T cells, rapamycin treatment, alanine mutagenesis of phosphorylation sites, ChIP\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mass spectrometry identification + mutagenesis + chromatin readout\",\n      \"pmids\": [\"28424242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Egr2 and Egr3 physically interact with the T-box domain of T-bet, blocking T-bet DNA binding and inhibiting T-bet-mediated IFN-gamma production in CD4+ and CD8+ effector T cells.\",\n      \"method\": \"Co-immunoprecipitation of Egr2/3 with T-bet T-box domain, T-bet DNA binding assays, Egr2/3 KO T cells, in vitro Th1 differentiation and virus infection model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct protein-protein interaction mapped to T-box domain plus functional KO validation\",\n      \"pmids\": [\"28455436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"T-bet-expressing B cells (conditional T-bet deletion from B cells) drive germinal center formation and IgG autoantibody production in SLE; B cell-specific T-bet deletion impairs GC formation and mitigates kidney damage in lupus-prone mice.\",\n      \"method\": \"Conditional B cell-specific T-bet deletion, spontaneous SLE mouse models, GC and autoantibody analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with defined molecular and pathological readouts\",\n      \"pmids\": [\"28240602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"T-bet+ Treg cells become highly stable even under non-permissive conditions; loss of T-bet-expressing Treg cells (but not T-bet expression within Tregs) causes severe Th1 autoimmunity; T-bet+ Tregs specifically inhibit Th1 and CD8 T cell activation consistent with their co-localization with T-bet+ effectors.\",\n      \"method\": \"T-bet fate-mapping in Treg cells, selective depletion of T-bet+ Tregs, adoptive transfer, infection models in mice\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — fate-mapping plus selective depletion establishing functional necessity\",\n      \"pmids\": [\"28607488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP10, a ubiquitin-processing protease, interacts with T-bet in the nucleus and directly inhibits T-bet ubiquitination, thereby increasing T-bet protein stability; the T-bet inhibitor Quercetin targets USP10, promoting T-bet proteasomal degradation.\",\n      \"method\": \"Co-immunoprecipitation (USP10 with T-bet), overexpression assays, ubiquitination assays, proteasome inhibitor studies\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP and ubiquitination assays, single study with moderate mechanistic follow-up\",\n      \"pmids\": [\"24845384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sp1 is a positive transcriptional regulator of human T-BET: six Sp1-binding sites in the proximal T-BET promoter are highly conserved; EMSA demonstrates physical Sp1-promoter association; ectopic Sp1 enhances T-BET expression and cytokine-induced IFN-gamma in NK and T cells; mithramycin A blocks Sp1 binding and diminishes T-BET and IFN-gamma.\",\n      \"method\": \"EMSA, luciferase reporter assays, Sp1 overexpression, mithramycin A treatment in primary human NK cells\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA + reporter assays + gain/loss-of-function in primary human cells\",\n      \"pmids\": [\"17705132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"T-bet is an innate target in myeloid cells that directly regulates IL-36gamma transcription; promoter analysis revealed a T-bet binding site enabling efficient IL-36gamma induction; ectopic T-bet expression in keratinocytes (which lack T-bet) is sufficient to mediate IL-36gamma production.\",\n      \"method\": \"siRNA knockdown + genome-wide mRNA expression, promoter analysis (T-bet binding site identification), T-bet KO dendritic cells, ectopic T-bet expression in HaCaT keratinocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — promoter mapping + siRNA + KO + ectopic expression across multiple cell types\",\n      \"pmids\": [\"23095752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NEDD4L mediates T-bet ubiquitination and degradation in CD4+ T cells downstream of the DP1/PKA/p-Sp1/NEDD4L pathway; forced NEDD4L expression or T-bet deletion in CD4+ T cells attenuates age-related hypertension.\",\n      \"method\": \"CD4+ T cell-specific DP1 KO and T-bet KO mice, NEDD4L overexpression, T-bet ubiquitination assays, telemetric blood pressure monitoring\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ubiquitination assays plus in vivo genetic models, single study\",\n      \"pmids\": [\"31893939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"c-Maf directly restrains T-bet expression in CCR6- ILC3s and forms a negative feedback loop: T-bet induces c-Maf while c-Maf limits T-bet-driven type 1 programming; loss of c-Maf results in hyper type 1 differentiation with overexpression of ILC1/NK-related genes.\",\n      \"method\": \"c-Maf KO ILC3 phenotyping, transcriptomic profiling, chromatin analysis, genetic epistasis with T-bet\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO + transcriptomic + epistasis establishing direct regulatory relationship\",\n      \"pmids\": [\"32039762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EOMES and T-BET regulate largely distinct gene sets during NK cell maturation, binding to largely overlapping DNA targets; EOMES drives early lineage specification while T-BET dominates in mature NK cells inducing IL-12 responsiveness and repressing the cell cycle; extensive epigenetic changes accompany this T-BET-driven maturation.\",\n      \"method\": \"Gene-modified mice with endogenous EOMES/T-BET for ChIP, ChIP-seq, ATAC-seq, NK cell developmental analysis in KO mice\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP-seq of endogenous proteins + epigenomic analysis + KO phenotypes\",\n      \"pmids\": [\"34521844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human T-bet governs the development of a distinct CD11c+CD21low B cell subset by controlling chromatin accessibility of lineage-defining genes (FAS, IL21R, SEC61B, DUSP4, DAPP1, SOX5, CD79B, CXCR4); T-bet-deficient patients lack this B cell subset and show skewed class switching to IgG1/IgG4/IgE with reduced IgG2.\",\n      \"method\": \"Patient with inherited T-bet deficiency, ATAC-seq (chromatin accessibility), in vitro B cell differentiation assays, in vivo immunoglobulin isotype analysis\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — human genetic loss-of-function with chromatin accessibility mapping of direct targets\",\n      \"pmids\": [\"35867801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Wild-type T-bet, but not patient mutant T-bet, inhibits Th2 cytokine production (IL-4, IL-5, IL-9, IL-13) when overexpressed in Th2 cells; T-bet deficiency causes CD4+ αβ T cells to overproduce Th2 cytokines, causing eosinophilia and upper airway inflammation.\",\n      \"method\": \"Overexpression of WT vs. mutant T-bet in Th2 cells, Herpesvirus saimiri-immortalized T cells from T-bet-deficient patient, cytokine measurement, patient phenotyping\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — natural human experiment with WT vs. mutant rescue, multiple functional readouts\",\n      \"pmids\": [\"34160550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Expansion of human T-bethigh CD21low B cells requires combined BCR/IFNgamma receptor costimulation and is dependent on canonical NF-kappaB, CD40, IL-21 receptor, and IFNg/STAT1 signaling; TLR signaling via MyD88/IRAK4 is not required. Expansion correlates with circulating Tfh1 and Tph cells as sources of CD40L, IL-21, and IFNgamma.\",\n      \"method\": \"In vitro differentiation with defined cytokines/TLR ligands, patients with defined inborn errors of immunity (NF-kappaB, CD40, IL-21R, IFNgR, STAT1, MyD88/IRAK4 deficiencies), flow cytometry, transcriptomic and chromatin accessibility analysis\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — natural human genetic experiments across multiple signaling pathways plus in vitro reconstitution\",\n      \"pmids\": [\"34623902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"T-BET expression in Treg cells is required for CXCR3 expression and accumulation of Treg cells in pancreatic islets; genetic ablation of T-BET from Treg cells increases diabetes onset and penetrance in NOD mice by failing to control type 1 cytokine responses.\",\n      \"method\": \"T-BET conditional KO in Treg cells (NOD mice), CXCR3 expression analysis, insulitis scoring, cytokine measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional cell-type-specific KO with mechanistic (CXCR3) and disease readouts\",\n      \"pmids\": [\"27872297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tbx21 locus exhibits bivalent H3K4/H3K27 trimethylation marks in Th17 cells; IL-12 stimulation removes H3K27 trimethylation at Tbx21, enabling T-bet upregulation and Th17-to-Th1 plasticity.\",\n      \"method\": \"ChIP for H3K4me3 and H3K27me3 at Tbx21, Rorc, Il17a, Ifng, Il12rb2 loci in ex vivo and in vitro Th17 cells, in vivo immunization\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based epigenetic mechanism at T-bet locus, single study\",\n      \"pmids\": [\"21307296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tbx21 gene is expressed in mitral and tufted cells of the olfactory bulb; a ~300 nucleotide enhancer element at ~3.0 kb upstream of the Tbx21 transcription start site is both necessary and sufficient for transgene expression in mitral and tufted cells, revealing a non-immune role for the Tbx21 locus.\",\n      \"method\": \"Transgenic mice with various lengths of Tbx21 5' upstream region fused to gapVenus reporter, promoter/enhancer deletion analysis\",\n      \"journal\": \"Neural systems & circuits\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional enhancer mapping in vivo via transgenic reporter analysis\",\n      \"pmids\": [\"22330144\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"T-bet (TBX21) is a T-box transcription factor that acts as the master regulator of type 1 immune responses: it directly binds the IFN-gamma and other target gene promoters/enhancers (including IL-23R, Tim-3, IL-36gamma, CXCR3, CD122, and FUT7) and recruits Mediator, P-TEFb/SEC, and chromatin remodeling complexes to drive transcriptional elongation; it is induced by IFN-gamma via STAT1 and by IL-12 via STAT4 through a distal enhancer, and its mRNA is stabilized by Arid5a binding the 3'UTR while its protein stability is regulated by USP10-mediated deubiquitination and NEDD4L-mediated ubiquitination; T-bet operates across innate and adaptive immune compartments—governing Th1 CD4+ T cell commitment, CD8+ effector/memory fate decisions, ILC maturation, NK cell terminal differentiation, NKT cell development, B cell IgG2a class switching, and Treg functional specialization—through combinatorial interactions with transcription factors including Runx3, GATA-3, Egr2/3, and c-Maf, making it a pivotal coordinator of type 1 immunity whose dysregulation drives autoimmunity, inflammatory disease, and impaired pathogen clearance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TBX21 (T-bet) is a T-box transcription factor that serves as the master regulator of type 1 immune responses across both innate and adaptive immune compartments, governing Th1 CD4+ T cell commitment, CD8+ effector/memory fate, ILC maturation, NK cell terminal differentiation, NKT cell development, B cell IgG2a class switching, and Treg functional specialization [PMID:10761931, PMID:16357323, PMID:23334414, PMID:34521844, PMID:28607488]. T-bet directly transactivates the IFN-gamma gene and additional targets including CXCR3, CD122, Tim-3, IL-23R, IL-36γ, and FUT7 by recruiting Mediator and the super elongation complex (P-TEFb/SEC) to enhancers, thereby promoting transcriptional elongation of poised genes [PMID:27292648, PMID:17339440, PMID:17075044]. Its expression is induced by IFN-γ/STAT1 and IL-12/STAT4 through a distal enhancer, with additional transcriptional input from Notch1 and Sp1, post-transcriptional stabilization of its mRNA by Arid5a, and protein-level regulation through USP10-mediated deubiquitination and NEDD4L-mediated ubiquitin-dependent degradation [PMID:11752460, PMID:17575072, PMID:15991363, PMID:27671645, PMID:24845384, PMID:31893939]. T-bet simultaneously represses alternative lineage programs—suppressing Th2 cytokines through antagonism of GATA-3, Th17 responses through RORγt suppression, and central-memory CD8+ differentiation through IL-7Rα repression—while its activity is modulated by physical interactions with Runx3, Egr2/3, and c-Maf [PMID:12882831, PMID:20974984, PMID:17698591, PMID:28455436, PMID:25148025, PMID:32039762].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"The discovery that T-bet directly transactivates IFN-γ and redirects Th2 cells to a Th1 fate established TBX21 as the master transcription factor for Th1 lineage commitment, answering the long-standing question of what drives Th1 specification.\",\n      \"evidence\": \"Retroviral transduction of T-bet into polarized Th2/Tc2 primary T cells with cytokine and transcription assays\",\n      \"pmids\": [\"10761931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide direct target repertoire not yet defined\", \"Mechanism of Th2 gene repression not established\", \"Role beyond T cells unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification that T-bet targets chromatin remodeling to individual IFN-γ alleles and induces IL-12Rβ2 expression, and that T-bet itself is induced by IFN-γ/STAT1, established the positive-feedback loop (IFN-γ → STAT1 → T-bet → IFN-γ) and placed T-bet upstream of IL-12 signaling.\",\n      \"evidence\": \"Allele-specific chromatin remodeling assays plus IFN-γ/STAT1/STAT4-deficient mice and in vivo infection models\",\n      \"pmids\": [\"11397944\", \"11752460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise chromatin remodeling complexes recruited by T-bet not identified\", \"Whether STAT4 independently regulates T-bet expression not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstration that T-bet directly regulates IgG2a class switching in B cells extended its functional role beyond T cells, establishing T-bet as a lineage-specifying factor in multiple immune compartments.\",\n      \"evidence\": \"T-bet KO B cells, retroviral overexpression, germline transcript analysis for IgG2a switching\",\n      \"pmids\": [\"11960012\", \"12882831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether T-bet directly binds the IgG2a switch region or acts indirectly not determined\", \"Relevance to human B cell class switching unconfirmed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"ChIP demonstrated direct T-bet binding to IFN-γ and STAT1 promoters, and genetic epistasis showed T-bet is dominant over STAT1 for encephalitogenicity, resolving the hierarchy between T-bet and STAT1 in autoimmune pathogenesis.\",\n      \"evidence\": \"ChIP for T-bet on IFN-γ/STAT1 promoters; T-bet/STAT1 single and double KO mice in EAE\",\n      \"pmids\": [\"15539157\", \"15238607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which T-bet drives pathogenicity independent of IFN-γ not identified\", \"Specific T-bet cofactors at these promoters unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Notch1 was identified as a direct upstream transcriptional regulator of Tbx21, and T-bet was shown to control NKT cell maturation, broadening the upstream signaling inputs and downstream immune cell types governed by T-bet.\",\n      \"evidence\": \"Notch1 binding to Tbx21 promoter plus gamma-secretase inhibitor studies; ectopic T-bet expression in immature NKT cells with microarray profiling\",\n      \"pmids\": [\"15991363\", \"16357323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of Notch1, STAT1, and STAT4 to T-bet induction in different cell types not quantified\", \"Whether Notch-T-bet axis operates in all T-bet-expressing lineages unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Multiple studies established that T-bet controls target gene-specific programs in distinct immune compartments: CXCR3-dependent migration versus cytotoxicity in CD8+ T cells, FUT7 via antagonism of GATA-3, and DC-intrinsic cytokine production required for inflammatory arthritis.\",\n      \"evidence\": \"CXCR3 retroviral reconstitution in T-bet KO CD8+ T cells; EMSA/co-IP of T-bet-GATA3 on FUT7 promoter; adoptive transfer of T-bet+ DCs in arthritis model\",\n      \"pmids\": [\"17056513\", \"17075044\", \"16410834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full spectrum of T-bet direct versus indirect targets in each cell type not delineated\", \"Structural basis of T-bet/GATA-3 antagonism not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"A temporal dissection using inducible T-bet-ER fusion identified IFN-γ, CD122, and CXCR3 as acute direct targets, while enhancer mapping revealed a distal IL-12/STAT4- and IFN-γ/STAT1-responsive element controlling T-bet expression, defining both inputs and outputs with temporal precision.\",\n      \"evidence\": \"Tamoxifen-inducible T-bet-ER system; luciferase reporter assays with enhancer mutagenesis; Sp1 EMSA on T-bet promoter; T-bet KO CD8+ memory/effector cell analysis\",\n      \"pmids\": [\"17339440\", \"17575072\", \"17705132\", \"17698591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all acute targets represent direct DNA binding or require cofactors not fully resolved\", \"Kinetic hierarchy among direct targets unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"T-bet was shown to be required for encephalitogenicity of myelin-specific T cells independent of whether they produce IFN-γ or IL-17, revealing a cytokine-independent pathogenicity program controlled by T-bet.\",\n      \"evidence\": \"Adoptive transfer of Th1 or Th17 differentiated myelin-specific TCR transgenic T cells into EAE mice\",\n      \"pmids\": [\"19546248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular effectors of this cytokine-independent T-bet pathogenicity program not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"T-bet was found to directly induce Tim-3 (a Th1 counter-regulatory receptor) and to suppress Th17 responses (IL-17A/F, RORγt) through a STAT1-independent mechanism, establishing T-bet as both an activator and a self-limiting regulator of Th1 responses.\",\n      \"evidence\": \"T-bet KO/overexpression for Tim-3 analysis; ectopic T-bet in STAT1-deficient T cells for Th17 suppression\",\n      \"pmids\": [\"20049876\", \"20974984\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Tim-3 regulation is a direct promoter event not confirmed by ChIP\", \"Molecular mechanism of STAT1-independent Th17 suppression unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"T-bet was established as essential for ILC biology: required cell-intrinsically for NKp46+ ILC generation and IL-22 production, and for suppressing IL-7R on ILCs to control intestinal homeostasis; its loss in innate cells drives colitis and regulates IL-36γ in myeloid cells.\",\n      \"evidence\": \"T-bet KO bone marrow chimeras for ILC analysis; TRUC (Tbx21−/−Rag2−/−) mice for colitis; T-bet KO DCs and ectopic expression in keratinocytes for IL-36γ\",\n      \"pmids\": [\"23209316\", \"23063332\", \"23095752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Graded T-bet dosage effects on ILC fate decisions not yet defined\", \"Epigenetic mechanism at Tbx21 locus during ILC development not characterized\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Graded T-bet expression was shown to control fate decisions in RORγt+ ILCs, instructing IFN-γ production and NKp46 expression for protection against Salmonella, establishing a dose-dependent model for T-bet function in innate lymphoid cells.\",\n      \"evidence\": \"T-bet KO mice with commensal manipulation, IL-23 stimulation, Salmonella infection, genetic fate-mapping\",\n      \"pmids\": [\"23334414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis by which T-bet dosage is translated into distinct ILC fates not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"T-bet was found to cooperate with Runx3 to suppress conventional CD4+ T helper functions and induce the CD8αα+ intraepithelial lymphocyte program, and USP10 was identified as a deubiquitinase stabilizing T-bet protein.\",\n      \"evidence\": \"T-bet/Runx3 loss- and gain-of-function for IEL program; co-IP of USP10 with T-bet plus ubiquitination assays\",\n      \"pmids\": [\"25148025\", \"24845384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of T-bet–Runx3 cooperation not determined\", \"USP10–T-bet interaction awaits independent confirmation and structural mapping\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The elongation mechanism was resolved: T-bet activates Th1 genes by recruiting Mediator and P-TEFb/SEC to enhancers to convert poised RNA Pol II into productive elongation, independent of RelA and Brd4; T-bet mRNA was shown to be stabilized by Arid5a binding to a 3′UTR stem-loop; T-bet in Tregs drives CXCR3 expression and islet-accumulation to restrain type 1 diabetes.\",\n      \"evidence\": \"ChIP-seq/P-TEFb inhibition/Mediator knockdown; Arid5a KO mice with RNA-binding assays; Treg-specific T-bet conditional KO in NOD mice\",\n      \"pmids\": [\"27292648\", \"27671645\", \"27872297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the elongation mechanism applies equally to all T-bet target loci not tested\", \"Full repertoire of RNA-binding proteins regulating T-bet mRNA unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple regulatory layers were defined: mTORC1-dependent phosphorylation at specific T-bet sites controls chromatin complex recruitment; Egr2/3 physically block the T-box DNA-binding domain; T-bet+ Tregs are functionally essential for suppressing Th1/CD8 responses; and B cell-intrinsic T-bet drives lupus germinal center formation.\",\n      \"evidence\": \"Mass spectrometry of T-bet phosphosites plus mutagenesis; co-IP mapping Egr2/3 to T-box domain; T-bet fate-mapping and depletion in Tregs; conditional B cell-specific T-bet deletion in lupus mice\",\n      \"pmids\": [\"28424242\", \"28455436\", \"28607488\", \"28240602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinases directly phosphorylating T-bet downstream of mTORC1 not identified\", \"How T-bet+ Tregs acquire distinct suppressive mechanisms versus effector T-bet+ cells not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NEDD4L was identified as the E3 ligase mediating T-bet ubiquitination and degradation, and c-Maf was shown to form a negative feedback loop with T-bet in ILC3s restraining type 1 programming.\",\n      \"evidence\": \"NEDD4L overexpression and T-bet ubiquitination assays in CD4+ T cells with hypertension model; c-Maf KO ILC3 transcriptomic and chromatin analysis with T-bet epistasis\",\n      \"pmids\": [\"31893939\", \"32039762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NEDD4L is the sole E3 ligase for T-bet not established\", \"Relative contributions of USP10 versus NEDD4L in different cell types not compared\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Human inherited T-bet deficiency established its non-redundant roles: T-bet governs chromatin accessibility at lineage-defining loci in CD11c+CD21low B cells and is required for Th2 suppression and IgG2 class switching; EOMES and T-bet were shown to regulate largely distinct gene sets during NK maturation despite overlapping DNA binding.\",\n      \"evidence\": \"Human T-bet-deficient patient with ATAC-seq and in vitro differentiation; WT vs. mutant T-bet rescue in Th2 cells; endogenous ChIP-seq/ATAC-seq of EOMES and T-bet in NK cells; human inborn errors of immunity panel for T-bet+ B cell requirements\",\n      \"pmids\": [\"35867801\", \"34160550\", \"34521844\", \"34623902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full phenotypic spectrum of human T-bet deficiency not yet characterized\", \"How T-bet and EOMES partition target gene regulation at shared binding sites not mechanistically resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of T-bet interactions with its diverse partner transcription factors, the complete catalog of direct T-bet targets across all expressing cell types, and the mechanisms by which graded T-bet expression produces qualitatively distinct cell fates.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of T-bet in complex with any partner or DNA\", \"Genome-wide direct target maps across all T-bet-expressing lineages not available\", \"Dose-dependent mechanism converting T-bet levels into distinct ILC/T cell fates not molecularly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 5, 12, 25, 33]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 12, 15, 25, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 25, 31, 36]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 3, 8, 21, 23, 30, 37, 38]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 5, 25, 33]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 16, 27]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 25, 37]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GATA3\", \"RUNX3\", \"EGR2\", \"EGR3\", \"USP10\", \"NEDD4L\", \"ARID5A\", \"MAF\"],\n    \"other_free_text\": []\n  }\n}\n```"}